Development and Validation of the Generalized Anxiety Disorder Inventory (GADI)

S.V. Argyroulos, G.B. Ploubidis, T.S. Wright, M.E. Palm, Sean Hood, J.R. Nash, A.C. Taylor, S.W. Forshall, I.M. Anderson, D.J. Nutt, J.P. Potokar

    Research output: Contribution to journalArticle

    19 Citations (Scopus)

    Abstract

    The psychometric tools used for the assessment of generalized anxiety disorder (GAD) either do not conform to the current concept of the condition or have important limitations. We aimed to develop and validate a new questionnaire for the assessment of symptom profile and severity of GAD.An original pool of potential scale items was subjected to a series of studies in non-clinical and clinical populations, in order to determine the final composition of the scale. The psychometric properties of the new scale, the Generalized Anxiety Disorder Inventory (GADI), were evaluated using a factor analytic model suitable for ordinal data and the Graded Response Model. The precision of measurement of the GADI was quantified through the item information functions.A total of 197 outpatients and 522 non-clinical subjects participated in four studies and completed the GADI. The final 18-item scale was derived from an original pool of 30 potential items. The GADI showed good reliability, convergent and divergent validity. The scale comprises three factors, relating to cognitive, somatic and sleep symptoms. It accurately distinguished GAD patients from non-patient controls. The cognitive factor also distinguished GAD from other anxiety disorders and depression.The GADI is a useful tool in the assessment of the breadth of symptoms and the severity of generalized anxiety disorder in clinical settings.
    Original languageEnglish
    Pages (from-to)145-152
    JournalJournal of Psychopharmacology
    Volume21
    Issue number2
    DOIs
    Publication statusPublished - 2007

    Fingerprint

    Anxiety Disorders
    Equipment and Supplies
    Symptom Assessment
    Psychometrics
    Sleep
    Outpatients
    Depression

    Cite this

    Argyroulos, S. V., Ploubidis, G. B., Wright, T. S., Palm, M. E., Hood, S., Nash, J. R., ... Potokar, J. P. (2007). Development and Validation of the Generalized Anxiety Disorder Inventory (GADI). Journal of Psychopharmacology, 21(2), 145-152. https://doi.org/10.1177/0269881107069944
    Argyroulos, S.V. ; Ploubidis, G.B. ; Wright, T.S. ; Palm, M.E. ; Hood, Sean ; Nash, J.R. ; Taylor, A.C. ; Forshall, S.W. ; Anderson, I.M. ; Nutt, D.J. ; Potokar, J.P. / Development and Validation of the Generalized Anxiety Disorder Inventory (GADI). In: Journal of Psychopharmacology. 2007 ; Vol. 21, No. 2. pp. 145-152.
    @article{fe4dd7fab7bc481d890ce7173fa8b30c,
    title = "Development and Validation of the Generalized Anxiety Disorder Inventory (GADI)",
    abstract = "The psychometric tools used for the assessment of generalized anxiety disorder (GAD) either do not conform to the current concept of the condition or have important limitations. We aimed to develop and validate a new questionnaire for the assessment of symptom profile and severity of GAD.An original pool of potential scale items was subjected to a series of studies in non-clinical and clinical populations, in order to determine the final composition of the scale. The psychometric properties of the new scale, the Generalized Anxiety Disorder Inventory (GADI), were evaluated using a factor analytic model suitable for ordinal data and the Graded Response Model. The precision of measurement of the GADI was quantified through the item information functions.A total of 197 outpatients and 522 non-clinical subjects participated in four studies and completed the GADI. The final 18-item scale was derived from an original pool of 30 potential items. The GADI showed good reliability, convergent and divergent validity. The scale comprises three factors, relating to cognitive, somatic and sleep symptoms. It accurately distinguished GAD patients from non-patient controls. The cognitive factor also distinguished GAD from other anxiety disorders and depression.The GADI is a useful tool in the assessment of the breadth of symptoms and the severity of generalized anxiety disorder in clinical settings.",
    author = "S.V. Argyroulos and G.B. Ploubidis and T.S. Wright and M.E. Palm and Sean Hood and J.R. Nash and A.C. Taylor and S.W. Forshall and I.M. Anderson and D.J. Nutt and J.P. Potokar",
    year = "2007",
    doi = "10.1177/0269881107069944",
    language = "English",
    volume = "21",
    pages = "145--152",
    journal = "Journal of Psychopharmacology",
    issn = "0269-8811",
    publisher = "SAGE Publications Ltd",
    number = "2",

    }

    Argyroulos, SV, Ploubidis, GB, Wright, TS, Palm, ME, Hood, S, Nash, JR, Taylor, AC, Forshall, SW, Anderson, IM, Nutt, DJ & Potokar, JP 2007, 'Development and Validation of the Generalized Anxiety Disorder Inventory (GADI)' Journal of Psychopharmacology, vol. 21, no. 2, pp. 145-152. https://doi.org/10.1177/0269881107069944

    Development and Validation of the Generalized Anxiety Disorder Inventory (GADI). / Argyroulos, S.V.; Ploubidis, G.B.; Wright, T.S.; Palm, M.E.; Hood, Sean; Nash, J.R.; Taylor, A.C.; Forshall, S.W.; Anderson, I.M.; Nutt, D.J.; Potokar, J.P.

    In: Journal of Psychopharmacology, Vol. 21, No. 2, 2007, p. 145-152.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Development and Validation of the Generalized Anxiety Disorder Inventory (GADI)

    AU - Argyroulos, S.V.

    AU - Ploubidis, G.B.

    AU - Wright, T.S.

    AU - Palm, M.E.

    AU - Hood, Sean

    AU - Nash, J.R.

    AU - Taylor, A.C.

    AU - Forshall, S.W.

    AU - Anderson, I.M.

    AU - Nutt, D.J.

    AU - Potokar, J.P.

    PY - 2007

    Y1 - 2007

    N2 - The psychometric tools used for the assessment of generalized anxiety disorder (GAD) either do not conform to the current concept of the condition or have important limitations. We aimed to develop and validate a new questionnaire for the assessment of symptom profile and severity of GAD.An original pool of potential scale items was subjected to a series of studies in non-clinical and clinical populations, in order to determine the final composition of the scale. The psychometric properties of the new scale, the Generalized Anxiety Disorder Inventory (GADI), were evaluated using a factor analytic model suitable for ordinal data and the Graded Response Model. The precision of measurement of the GADI was quantified through the item information functions.A total of 197 outpatients and 522 non-clinical subjects participated in four studies and completed the GADI. The final 18-item scale was derived from an original pool of 30 potential items. The GADI showed good reliability, convergent and divergent validity. The scale comprises three factors, relating to cognitive, somatic and sleep symptoms. It accurately distinguished GAD patients from non-patient controls. The cognitive factor also distinguished GAD from other anxiety disorders and depression.The GADI is a useful tool in the assessment of the breadth of symptoms and the severity of generalized anxiety disorder in clinical settings.

    AB - The psychometric tools used for the assessment of generalized anxiety disorder (GAD) either do not conform to the current concept of the condition or have important limitations. We aimed to develop and validate a new questionnaire for the assessment of symptom profile and severity of GAD.An original pool of potential scale items was subjected to a series of studies in non-clinical and clinical populations, in order to determine the final composition of the scale. The psychometric properties of the new scale, the Generalized Anxiety Disorder Inventory (GADI), were evaluated using a factor analytic model suitable for ordinal data and the Graded Response Model. The precision of measurement of the GADI was quantified through the item information functions.A total of 197 outpatients and 522 non-clinical subjects participated in four studies and completed the GADI. The final 18-item scale was derived from an original pool of 30 potential items. The GADI showed good reliability, convergent and divergent validity. The scale comprises three factors, relating to cognitive, somatic and sleep symptoms. It accurately distinguished GAD patients from non-patient controls. The cognitive factor also distinguished GAD from other anxiety disorders and depression.The GADI is a useful tool in the assessment of the breadth of symptoms and the severity of generalized anxiety disorder in clinical settings.

    U2 - 10.1177/0269881107069944

    DO - 10.1177/0269881107069944

    M3 - Article

    VL - 21

    SP - 145

    EP - 152

    JO - Journal of Psychopharmacology

    JF - Journal of Psychopharmacology

    SN - 0269-8811

    IS - 2

    ER -